Literature DB >> 11598445

Role of percutaneous image-guided biopsy in the evaluation of renal masses.

I Hara1, H Miyake, S Hara, S Arakawa, K Hanioka, S Kamidono.   

Abstract

OBJECTIVE: The objective of the present study was to evaluate the indications, accuracy, complications and impact of image-guided percutaneous biopsy of renal masses.
MATERIALS AND METHODS: Between 1994 and 1999, percutaneous biopsies under ultrasonography or computerized tomography guidance were performed in 33 patients with renal mass (22 men and 11 women, mean age 57.5 years, range 21-88). We retrospectively analyzed the relationship between clinical and histopathological findings, and discuss the appropriateness of the indications for image-guided percutaneous biopsy in the diagnosis of renal masses.
RESULTS: The indications used in our institution were as follows: (1) clinical and radiological findings to suggest a diagnosis other than primary renal cell carcinoma (RCC) (n = 15); (2) suspicious lesions of RCC in multiple cystic renal masses (n = 7); (3) differentiation of transitional cell carcinoma of the renal pelvis from RCC (n = 7); (4) differentiation of angiomyolipoma from RCC (n = 4). Sufficient amounts of tissues were obtained from all patients for pathological diagnosis. Among 33 patients, 21 (63.6%) were diagnosed positive for malignancy, and 15 underwent surgical intervention. The histopathological findings between percutaneous biopsy and surgically resected tissue were identical in 13 cases (86.7%). No patient developed major complications requiring surgical treatment.
CONCLUSION: If performed under appropriate selection of patients, percutaneous image-guided biopsy is a safe, reliable and accurate method of managing suspicious and/or indeterminate renal mass, and may contribute to the selection of appropriate clinical management by avoiding unnecessary procedures. Copyright 2001 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2001        PMID: 11598445     DOI: 10.1159/000050987

Source DB:  PubMed          Journal:  Urol Int        ISSN: 0042-1138            Impact factor:   2.089


  8 in total

1.  The role of percutaneous renal biopsy in the management of small renal masses.

Authors:  Rou Wang; Amy Y Li; David P Wood
Journal:  Curr Urol Rep       Date:  2011-02       Impact factor: 3.092

2.  Renal mass biopsy to guide treatment decisions for small incidental renal tumors: a cost-effectiveness analysis.

Authors:  Pari V Pandharipande; Debra A Gervais; Rebecca I Hartman; Mukesh G Harisinghani; Adam S Feldman; Peter R Mueller; G Scott Gazelle
Journal:  Radiology       Date:  2010-09       Impact factor: 11.105

3.  Molecular characterization of kidney cancer: association of hyaluronic acid family with histological subtypes and metastasis.

Authors:  Andrew Chi; Samir P Shirodkar; Diogo O Escudero; Obi O Ekwenna; Travis J Yates; Rajinikanth Ayyathurai; Michael Garcia-Roig; Jeffrey C Gahan; Murugesan Manoharan; Vincent G Bird; Vinata B Lokeshwar
Journal:  Cancer       Date:  2011-09-01       Impact factor: 6.860

4.  An important step in establishing a treatment strategy for small renal masses of clear cell renal cell carcinoma based on the significance of adverse histopathologic features on tumor needle biopsy.

Authors:  Suguru Kadomoto; Tomoyuki Makino; Kouji Izumi; Atsushi Mizokami
Journal:  Ann Transl Med       Date:  2019-12

5.  Pyogenic renal abscess masquerading as malignancy.

Authors:  Mayank Baid; Utpal De; Manoranjan Kar
Journal:  N Am J Med Sci       Date:  2013-03

Review 6.  Heterogeneity and renal mass biopsy: a review of its role and reliability.

Authors:  Jeffrey J Tomaszewski; Robert G Uzzo; Marc C Smaldone
Journal:  Cancer Biol Med       Date:  2014-09       Impact factor: 4.248

7.  Diagnostic significance of biopsies in renal masses.

Authors:  Bayram Dogan; Serkan Altinova; Ahmet Tunc Ozdemir; Muhammed Fuat Ozcan; Erem Asil; Ziya Akbulut; Mevlana Derya Balbay
Journal:  Cent European J Urol       Date:  2014-12-05

Review 8.  Renal Tumor Biopsy Technique.

Authors:  Lei Zhang; Xue-Song Li; Li-Qun Zhou
Journal:  Chin Med J (Engl)       Date:  2016-05-20       Impact factor: 2.628

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.